[P28] Poster Session 28　Lung Cancer/Thoracic Cancer（EGFR TKI）

[P28-5] Monitoring of Plasma EGFR Mutations during Osimertinib Therapy for NSCLC Patients with Acquired T790M Mutation

^○Kana Watanabe (Department of Respiratory Medicine, Miyagi Cancer Center)